Risk factors for small-intestinal mucosal breaks beyond aspirin

J Gastroenterol Hepatol. 2022 Aug;37(8):1596-1602. doi: 10.1111/jgh.15892. Epub 2022 May 31.

Abstract

Background and aim: There remains lots of unknowns for small intestinal mucosal breaks (SIMBs). The application of magnetic controlled capsule endoscope (MCCE) may provide a better understanding of SIMBs. The aim of our study was to investigate the prevalence and characteristics of SIMBs in the general population as well as risk factors for SIMBs other than aspirin.

Methods: Clinical data on individuals who visited our institute between January 2019 and February 2021 for MCCE examination as a health check were collected and analyzed retrospectively. All study participants must have completed the small bowel inspection. Multivariate analysis was employed to reveal the independent risk factors for SIMBs.

Results: A total of 1599 participants, 103 of whom were aspirin users, were finally included. The prevalence of SIMBs was 8.3% (132/1599) in all participants, with 36.9% (38/103) in aspirin users and 6.3% (94/1496) in non-aspirin users. The multivariate analysis showed that in addition to aspirin (OR: 6.17, 95% CI: 3.25-11.58), obesity (OR: 2.30, 95% CI: 1.38-3.92) and smoking (OR: 1.85, 95% CI: 1.56-3.20) were also independent risk factors for SIMBs. Jejunum involvement was more common in aspirin users (20/38, 52.6%), while ilium involvement was more common in non-aspirin users (58/94, 61.7%). Moderate SIMBs (erosions) were more common in aspirin users (17/38, 44.7%), while severe SIMBs (large erosions/ulcers) were more common in non-aspirin users (17/94, 18.1%).

Conclusions: The risk factors for SIMBs include aspirin as well as smoking and obesity, and the severity and distributive features of SIMBs differ between aspirin users and non-aspirin users.

Keywords: aspirin; gut microbiota; magnetic controlled capsule endoscope; small intestinal mucosal breaks.

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Aspirin* / adverse effects
  • Capsule Endoscopy*
  • Humans
  • Intestinal Mucosa
  • Obesity
  • Retrospective Studies
  • Risk Factors

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Aspirin